TP53 and neoplasm: We have shown previously that inhibition of mitochondrial ETC specifically within complex III results in an activation of the p53 tumor suppressor because of an impairment of the de novo pyrimidine biosynthesis.8 We show that the activation of p53 can modify the ISR induced by mitochondrial dysfunction.